Publications by authors named "Amanda J Schech"

Claim this Profile
H
Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.
Amanda J Schech, Preeti Shah, Stephen Yu, Gauri J Sabnis, Olga Goloubeva

Breast Cancer Res Treat· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
Armina A Kazi, Rabia A Gilani, Amanda J Schech, Saranya Chumsri, Gauri Sabnis

Breast Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid reverses the epithelial-mesenchymal transition and inhibits self-renewal of breast cancer cells through inactivation of NF-κB.
Amanda J Schech, Armina A Kazi, Rabia A Gilani, Angela H Brodie

Mol Cancer Ther· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid inhibits aromatase activity and phosphorylation: potential mechanism for additive zoledronic acid and letrozole drug interaction.
Amanda J Schech, Brandon E Nemieboka, Angela H Brodie

J Steroid Biochem Mol Biol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.
Rabia A Gilani, Armina A Kazi, Preeti Shah, Amanda J Schech, Saranya Chumsri

Breast Cancer Res Treat· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis